|
|||||
|
|
Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076) |
|
| Authors: | Elizabeth E Tolley Sue Li Sahar Z Zangeneh Millicent Atujuna Petina Musara Jessica Justman Subash Pathak Linda‐Gail Bekker Shobha Swaminathan Jill Stanton Jennifer Farrior Nirupama Sista |
| Abstract: | |
| Keywords: | HIV prevention clinical trial acceptability PrEP injectable women |